Tao Yu

Department of Oncology, Tianjin Medical University General Hospital

Affiliated withTianjin Medical University General Hospital The First Affiliated Hospital of Nanchang Medical College

Research Area

Cancer Research Immunology and Infection

Biography

Tao Yu has not added Biography.
If you are Tao Yu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title	2024
Publication title	2025
Publication title	2026

Other Publications

Article	Year
[Clinical Value of Cell Block in the Diagnosis of Malignant Pleural Effusion]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 28641697	2017
Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro. International immunopharmacology\| PubMed ID: 29294439	2018
[Curative Effect of Aprepitant Preventing CINV]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 30309434	2018
[Clinical Development of Immunotherapy for Small Cell Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 30591100	2018
Retrospective study of the efficacy and toxicity of lobaplatin-etoposide chemotherapy in small cell lung cancer. Thoracic cancer\| PubMed ID: 30600898	2019
Molecular mechanism of acquired drug resistance in the EGFR-TKI resistant cell line HCC827-TR. Thoracic cancer\| PubMed ID: 32163227	2020
Intratumor heterogeneity: A new perspective on colorectal cancer research. Cancer medicine\| PubMed ID: 32853464	2020
The long non-coding RNA TSLC8 inhibits colorectal cancer by stabilizing . Cell cycle (Georgetown, Tex.)\| PubMed ID: 33218295	2020
Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis. Frontiers in oncology\| PubMed ID: 34722299	2021
Temporal heterogeneity of HER2 expression in metastatic gastric cancer: a case report. World journal of surgical oncology\| PubMed ID: 35578236	2022
Intraindividual Tumor Heterogeneity of Mismatch Repair Status in Metastatic Colorectal Cancer. Applied immunohistochemistry & molecular morphology : AIMM\| PubMed ID: 36409630	2023
Tumour purity as an underlying key factor in tumour mutation detection in colorectal cancer. Clinical and translational medicine\| PubMed ID: 37132162	2023
Parental Germline Mutations of a Patient with De Novo APC Mutation. Digestive diseases and sciences\| PubMed ID: 37639056	2023
Construction and validation of a nomogram for predicting overall survival of patients with stage III/IV early-onset colorectal cancer. Frontiers in oncology\| PubMed ID: 38660128	2024
Dual-Specificity Phosphatase 4 Promotes Malignant Features in Colorectal Cancer Through Cyclic-AMP Response Element Binding Protein/Protein Kinase CAMP-Activated Catalytic Subunit Beta Activ... Digestive diseases and sciences\| PubMed ID: 38824257	2024
A competing-risk nomogram for predicting gastric cancer-specific survival in patients over 70 years: A SEER-based study. Cancer epidemiology\| PubMed ID: 39486271	2024
Worldwide Research Trends and Regional Differences in the Development of Precision Medicine Under Data-Driven Approach: A Bibliometric Analysis. Journal of multidisciplinary healthcare\| PubMed ID: 39563835	2024